Fig. 2

Kaplan–Meier curves for overall survival, CHR adolescents and CHR adults, by comparison (log-rank test) between AP− and AP+ groups at the end point of follow-up. AP− treated without antipsychotic medication, AP+ treated with antipsychotic medication, CHR clinical high risk for psychosis. AP− treated without antipsychotic medication, AP+ treated with antipsychotic medication, CHR clinical high risk for psychosis